# Immunomodulation Effect of Blood Transfusion

> **NCT02140216** · — · COMPLETED · sponsor: **Mahidol University** · enrollment: 60 (actual)

## Conditions studied

- Incompatible Blood Transfusion
- Immune Defect
- Surgery

## Interventions

- **BIOLOGICAL:** No blood transfusion
- **BIOLOGICAL:** Day 0 blood transfusion
- **BIOLOGICAL:** Day 1 or 2 blood transfusion

## Key facts

- **NCT ID:** NCT02140216
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-06-18
- **Final completion:** 2018-04-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140216, "Immunomodulation Effect of Blood Transfusion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02140216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*